Alignment Healthcare, Inc. (NASDAQ:ALHC) Insider Sells $63,807.48 in Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) insider Dawn Christine Maroney sold 7,074 shares of the stock in a transaction dated Thursday, August 22nd. The shares were sold at an average price of $9.02, for a total transaction of $63,807.48. Following the completion of the transaction, the insider now directly owns 1,789,023 shares of the company’s stock, valued at $16,136,987.46. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Dawn Christine Maroney also recently made the following trade(s):

• On Thursday, August 15th, Dawn Christine Maroney sold 20,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $8.70, for a total value of $174,000.00.
• On Friday, July 19th, Dawn Christine Maroney sold 36,700 shares of Alignment Healthcare stock. The stock was sold at an average price of $10.01, for a total value of $367,367.00.
• On Wednesday, July 17th, Dawn Christine Maroney sold 23,163 shares of Alignment Healthcare stock. The shares were sold at an average price of $10.00, for a total value of $231,630.00.
• On Wednesday, June 12th, Dawn Christine Maroney sold 20,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $8.21, for a total value of $164,200.00.

Alignment Healthcare Trading Up 2.8 %

Alignment Healthcare stock traded up $0.25 during trading on Friday, hitting $9.27. The company’s stock had a trading volume of 468,879 shares, compared to its average volume of 920,884. The stock’s fifty day moving average is $8.52 and its 200 day moving average is $6.92. Alignment Healthcare, Inc. has a 1-year low of $4.46 and a 1-year high of $10.16. The stock has a market capitalization of $1.77 billion, a price-to-earnings ratio of -11.04 and a beta of 1.43. The company has a debt-to-equity ratio of 1.23, a quick ratio of 1.57 and a current ratio of 1.57.

Alignment Healthcare (NASDAQ:ALHC) last posted its quarterly earnings data on Thursday, August 1st. The company reported ($0.13) EPS for the quarter, beating analysts’ consensus estimates of ($0.14) by $0.01. Alignment Healthcare had a negative net margin of 6.85% and a negative return on equity of 95.55%. The company had revenue of $681.29 million during the quarter, compared to the consensus estimate of $637.66 million. During the same quarter in the prior year, the company posted ($0.15) EPS. The company’s quarterly revenue was up 47.3% compared to the same quarter last year. As a group, equities research analysts predict that Alignment Healthcare, Inc. will post -0.67 EPS for the current year.

Hedge Funds Weigh In On Alignment Healthcare

Large investors have recently bought and sold shares of the stock. Virtu Financial LLC acquired a new stake in shares of Alignment Healthcare during the 1st quarter worth $57,000. Principal Financial Group Inc. purchased a new stake in Alignment Healthcare during the first quarter valued at about $57,000. Barlow Wealth Partners Inc. acquired a new stake in Alignment Healthcare during the fourth quarter worth about $100,000. Victory Capital Management Inc. raised its holdings in shares of Alignment Healthcare by 17.9% in the 4th quarter. Victory Capital Management Inc. now owns 12,935 shares of the company’s stock worth $111,000 after purchasing an additional 1,962 shares during the period. Finally, Aigen Investment Management LP lifted its stake in shares of Alignment Healthcare by 18.5% in the 4th quarter. Aigen Investment Management LP now owns 19,764 shares of the company’s stock valued at $170,000 after purchasing an additional 3,092 shares in the last quarter. Hedge funds and other institutional investors own 86.19% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have weighed in on ALHC. Stephens raised their target price on shares of Alignment Healthcare from $6.00 to $7.00 and gave the company an “equal weight” rating in a report on Friday, May 3rd. TD Cowen raised their price objective on shares of Alignment Healthcare from $8.00 to $10.00 and gave the stock a “buy” rating in a research note on Tuesday, August 6th. Piper Sandler reaffirmed an “overweight” rating and issued a $10.00 target price (up previously from $8.00) on shares of Alignment Healthcare in a research note on Tuesday, August 6th. Stifel Nicolaus raised their price target on Alignment Healthcare from $9.00 to $12.00 and gave the stock a “buy” rating in a research report on Friday, July 26th. Finally, Bank of America upgraded Alignment Healthcare from a “neutral” rating to a “buy” rating and upped their price objective for the company from $7.75 to $11.00 in a research report on Thursday, May 30th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, seven have assigned a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, Alignment Healthcare presently has a consensus rating of “Moderate Buy” and a consensus price target of $10.05.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.